Hello! It’s Rebecca here with your final Australia Briefing of 2024. And what a year it’s been. From the re-election of Donald Trump and the ongoing slowdown in China, to the blockbuster IPOs and corporate scandals closer to home -- 2024 will go down as one for the ages.
Before we all revert to the sanctity of our beach towels, I thought I’d load you up with a selection of my favorite pieces from Bloomberg’s Australia newsroom this year. A stockpile of stories, videos and podcasts to help you while away those days by the pool, at the campsite, or wherever the onset of summer takes you...
Read this…
Is ‘Bluey’ Ending? Disney’s Worried Biggest Kids Show Ever Is at Risk — Essential reading for anyone with a kid, or honestly, a pulse. Did you know that Americans watched 731 million hours of Bluey in 2023, more than NCIS, Grey’s Anatomy, Gilmore Girls or that perennial of the broadcast, cable and streaming eras, Friends? That’s almost as much as my kids.
Psychedelics Are Now Legal in Australia—With a Catch — Back in March, Bloomberg reporters Keira Wright and Michelle Cortez dived into the fascinating story of how an opera singer and her former banker husband managed to persuade Australia’s pharmaceutical regulators to clear MDMA and psilocybin (often known as mushrooms) for medical use.
It’s an enthralling tale, which we captured in this Bloomberg Originals documentary:
WATCH: Psychedelics Are Now Legal in Australia — But There’s a Catch
Each week, we seek to bring you Bloomberg’s unique take on the business, finance and economics stories that matter to Australia and the world through conversations with our fantastic reporters.
These are some of our most popular episodes so far:
You received this message because you are subscribed to Bloomberg's Australia Briefing newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.